FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / exhibit-g-ip-publication-rights.docx
exhibit-g-ip-publication-rights.docx · 1018-00004

Parties

Penterra Pharmaceuticals Corp

Dates

June 28, 2023
July 18, 2023

Amounts

$1,500,000

Obligations

gov Identifier: NCT05928174 IND Number: IND 157823 Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement
SECTION 1 — DEFINITIONS As used in this Exhibit G, the following terms shall have the meanings set forth below: 1
Clinical Trial Data shall include, without limitation, all data captured via the electronic data capture platform operated by Pinnacle Data Solutions, Inc
Clinical Trial Data shall not include a Participating Site's general medical records of trial subjects to the extent such records contain information unrelated to the Protocol
3 "Confidential Information" shall have the meaning set forth in the Agreement and Exhibit F (Confidentiality and Data Protection Provisions) attached thereto
For purposes of this Exhibit G, the obligations of confidentiality with respect to Confidential Information shall remain in effect for a period of ten (10) years from the date of disclosure of such Confidential Information, except with respect to trade secrets, which shall remain confidential for so long as they retain their trade secret status under applicable law